Asthma mortality in Southern Brazil between 2013 and 2022

a time series analysis

Authors

DOI:

https://doi.org/10.15448/1980-6108.2025.1.47158

Keywords:

Asthma, Mortality, COVID-19, Public Health

Abstract

Aims: To analyze asthma mortality in Rio Grande do Sul from 2013 to 2022 and understand the variation in asthma mortality over the years, including during the COVID-19 pandemic period. Methods: This is a descriptive time-series study with an ecological approach that analyzed asthma mortality in the state of Rio Grande do Sul, Brazil. Mortality data were extracted from the Mortality Information System, and population data were obtained from the 2010 and 2022 censuses. Results: A total of 1,885 deaths were identified in Rio Grande do Sul between 2013 and 2022, with a predominance of women (69.39%), an average age of 68.27 years (SD = 20.03), 65.22% hospitalized, and an average income of R$ 1,044.73 (SD = 441.35). A significant increase in the number of deaths and the mortality rate was observed over the period, with an annual percentage variation of 5.69%. Conclusion: Asthma mortality in Brazil remains significant and is increasing. We emphasize the importance of improvements in diagnosis, treatment, and public health actions for prevention and control.

Downloads

Download data is not yet available.

Author Biographies

Sheyla Velasques Paladini, Graduate Program in Pharmaceutical Services, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

PhD candidate in the Graduate Program in Pharmaceutical Services, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. Holds a master’s degree in health sciences: Cardiology and Cardiovascular Sciences. Specialist in Public Health from the Federal University of Rio Grande do Sul. Specialist in Health Informatics from the Federal University of São Paulo. Specialist in Data Science.

Marcelo Matieli da Silva Filho, Health Technology Assessment and Economics Group, Federal University of Espírito Santo, Alegre, Brazil.

Undergraduate student in the Pharmacy program at the Federal University of Espírito Santo and member of the Health Technology Assessment and Economics Group, Federal University of Espírito Santo, Alegre, Brazil.

Jéssica Barreto Ribeiro dos Santos, Health Technology Assessment and Economics Group, Federal University of Espírito Santo, Alegre, Brazil.

PhD and master’s degree in medicines and Pharmaceutical Services from the Federal University of Minas Gerais. Specialist in Health Economics and Technology Assessment from Hospital Oswaldo Cruz and the Institute of Economic Research Foundation. Specialist in Clinical Pharmacology from Newton Paiva University Center. Faculty member at the Federal University of Espírito Santo and member of the Health Technology Assessment and Economics Group, Federal University of Espírito Santo, Alegre, Brazil.

Michael Ruberson Ribeiro da Silva, Graduate Program in Pharmaceutical Services, Federal University of Espírito Santo, Alegre, Brazil.

PhD and master’s degree in medicines and Pharmaceutical Services from the Federal University of Minas Gerais. Specialist in Health Economics and Technology Assessment from Hospital Oswaldo Cruz and the Institute of Economic Research Foundation. Faculty member in the Graduate Program in Pharmaceutical Services, Federal University of Espírito Santo, Alegre, Brazil.

References

1. Brazil. Ministry of Health. Asthma [Internet]. Brasília: Ministry of Health; 2024 [cited 2024 Oct 15]. Available at: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/a/asma

2. Brazil. Ministry of Health. Joint Ordinance No. 14, of August 24, 2021 [Internet]. Brasília: Ministry of Health; 2021 [cited 2024 Jun 28]. Available at: https://www.gov.br/conitec/pt-br/midias/relatorios/portaria/2021/20210827_portaria_conjunta_14.pdf

3. Brazil. Ministry of Health. Asthma: proper diagnosis and treatment enable quality of life [Internet]. Brasília: EBSERH; 2024 [cited 2024 Oct 15]. Available at: https://www.gov.br/ebserh/pt-br/comunicacao/noticias/asma-diagnostico-e-tratamento-adequados-possibilitam-qualidade-de-vida

4. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention 2024 [Internet]. Fontana: GINA; 2024 [cited 2024 Oct 15]. Available at: https://ginasthma.org/2024-report/

5. Brazil. Ministry of Health. In one year, SUS recorded 1.3 million asthma cases in primary care [Internet]. Brasília: Ministry of Health; 2024 [cited 2024 Oct 15]. Available at: https://www.gov.br/saude/pt-br/assuntos/noticias/2022/maio/em-um-ano-sus-registrou-1-3-milhao-de-atendimentos-a-casos-de-asma-na-atencao-primaria

6. Borges GP, Pinto BF, Mendes CCR, Almeida EHS, Meneghete FHS, Martins IO et al. Asthma mortality rate in Brazil between 2018 and 2022. Iberoam J Humanit Sci Educ. 2024;10(4):622-32. https://doi.org/10.51891/rease.v10i4.13488

7. Pimentel LS, Ferreira GC. Comparison of asthma hospitalization prevalence rates in sentinel municipalities, Rio Grande do Sul, 2023. In: III National Congress of Trauma and Emergency Medicine [Internet]. 2023 Apr 8; Porto Alegre. Porto Alegre: LAUEC-AM; 2023. 1-2. Available at: https://www.even3.com.br/anais/traumaemergencia/796679-comparacao-de-prevalencias-de-internacoes-por-asma-em-municipios-sentinela-rio-grande-do-sul-2023

8. Secretariat of Health of Rio Grande do Sul (SESRS). Technical Note No. 60 – Mortality from respiratory diseases in Rio Grande do Sul [Internet]. Porto Alegre: SESRS; 2022 [cited 2024 Oct 15]. Available at: https://estado.rs.gov.br/upload/arquivos//nt-dee-60-indicadores-de-mortalidade-2022-07-26.pdf

9. Dasic B, Devic Z, Denic N, Zlatkovic D, Ilic ID, Cao Y et al. Human development index in a context of human development: review on the western Balkans countries. Brain Behav. 2020;10(9):e01755. https://doi.org/10.1002/brb3.1755

10. Sánchez-Hechavarría ME, Ghiya S, Carrazana-Escalona R, Cortina-Reyna S, Andreu-Heredia A, Acosta-Batista C et al. Introduction of application of Gini coefficient to heart rate variability spectrum for mental stress evaluation. Arq Bras Cardiol. 2019;113(4):725-33. https://doi.org/10.5935/abc.20190185

11. Bottomley C, Ooko M, Gasparrini A, Keogh RH. In praise of Prais-Winsten: an evaluation of methods used to account for autocorrelation in interrupted time series. Stat Med. 2023;42(8):1277-88. https://doi.org/10.1002/sim.9669

12. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-51. https://doi.org/10.1002/(SICI)1097-0258(20000215)19:3%3C335::AID-SIM336%3E3.0.CO;2-Z

13. Brito TS, Luiz RR, Silva JRLE, Campos HDS. Asthma mortality in Brazil, 1980-2012: a regional perspective. J Bras Pneumol. 2018;44(5):354-60. https://doi.org/10.1590/S1806-37562017000000235

14. Silva TLR, Carmo GS, Carmo JGS, Nascimento M, Oliveira GB, Alencar RB et al. Descriptive analysis of hospitalizations and deaths from asthma in northeastern Brazil: challenges in the context of the COVID-19 pandemic. Braz J Implantol Health Sci. 2024;6(2):397-406. https://doi.org/10.36557/2674-8169.2024v6n2p397-406

15. Costa VC, Barreto MP, Andrade MCC, Lopes SMS, Nascimento MML, Carvalho FP et al. Asthma as a risk factor for COVID-19 infection in children: an integrative review. Enferm Bras. 2023;22(4):492-506. https://doi.org/10.33233/eb.v22i4.5284

16. Adir Y, Saliba W, Beurnier A, Humbert M. Asthma and COVID-19: an update. Eur Respir Rev. 2021;30(162):210152. https://doi.org/10.1183/16000617.0152-2021

17. Ramos BG, Martins TBD, Castro MEPC. Asthma prevalence in the regions of Brazil: a systematic review. Braz J Hea Rev. 2021;4(3):11341-59. https://doi.org/10.34119/bjhrv4n3-133

18. Oliveira MA. Epidemiology of asthma: we need to broaden our concepts. J Bras Pneumol. 2018;44(5):341-2. https://doi.org/10.1590/S1806-37562018000050004

19. Oliveira MS, Montovani EH, Santana MFE, Ponce de Leon ACM, Marques MC. Mortality from chronic respiratory disease in Brazil: time trend and forecasts. Rev Saude Publica. 2022;13(56):52. https://doi.org/10.11606/s1518-8787.2022056003672

20. Marques CPC, Bloise RF, Lopes LBM, Godoi LF, Souza PRP, Santa Rosa IM et al. Epidemiology of asthma in Brazil, from 2016 to 2020. Res Soc Dev. 2022;11(8):e5211828825. https://doi.org/10.33448/rsd-v11i8.28825

21. Nazario NO, Lima Queiroz LNO, Ghizzo Filho J, Traebert JL. Temporal trend of hospitalization for asthma in adults, in the period 2008-2015, in the State of Santa Catarina, Brazil. Arq Catarin Med. 2018;47(3):85-99. https://doi.org/10.63845/shz8pp82

22. Macedo SE, Menezes AM, Knorst M, Dias-da-Costa JS, Gigante DP, Olinto MT et al. Fatores de risco para a asma em adultos, Pelotas, Rio Grande do Sul, Brasil. Cad Saude Publica. 2007;23(4):863-74. https://doi.org/10.1590/s0102-311x2007000400014

23. Asher MI, García-Marcos L, Pearce NE, Strachan DP. Trends in worldwide asthma prevalence. Eur Respir J. 2020;56(6):2002094. https://doi.org/10.1183/13993003.02094-2020

Downloads

Published

2025-07-30

How to Cite

Velasques Paladini, S., Matieli da Silva Filho, M., Barreto Ribeiro dos Santos, J., & Ruberson Ribeiro da Silva, M. (2025). Asthma mortality in Southern Brazil between 2013 and 2022: a time series analysis. Scientia Medica, 35(1), e47158. https://doi.org/10.15448/1980-6108.2025.1.47158

Issue

Section

Original Articles